INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

High blood pressure and telemedicine: past, present and future

Álvarez-López, Humberto

ABSTRACT

In a contemporary world accelerated by the COVID-19 pandemic, telemedicine has become an excellent option to offer remote consultations to control chronic degenerative diseases of high prevalence, such as hypertension, diabetes, and dyslipidemias. This review discusses precedents, ethical and legal aspects, and their current implementations towards managing high blood pressure (HBP). Although there are several reasons and clear benefits for implementing telemedicine, there are legal, ethical, and practical limitations and poor knowledge of its application within healthcare professionals. Appropriate ethical practice and an adequate legal framework within telemedicine will bypass all considerable risks related to quality, safety, and continuity of care associated with this practice. Regarding practical aspects, physician's clinical judgment is fundamental to know if it is possible to give medical consultation through telemedicine according to every patient's health requirement. Through diverse electronic and technological tools, the physicians could guarantee an appropriate medical consultation and handle follow-up visits. In general medicine, it could be possible that telemedicine would help to reduce the burden of care for patients with chronic diseases, decrease bureaucratic procedures, and support physicians practicing in isolated areas.
  FULL TEXT PDF   FLIPBOOK

Keywords

Telemedicine arteria hypertension ethical aspects




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Diagnostic challenge: cardiac myeloid sarcoma in a patient with acute myeloid...
    2025, Vol.36, Núm. 2
  • Atherogenic risk profiles and cardiovascular risk assessment in hospitalized...
    2025, Vol.36, Núm. 2
  • Case of coil dislodgement in saphenous vein graft coil occlusion in retrograde...
    2025, Vol.36, Núm. 2
  • Gym benefits?
    2025, Vol.36, Núm. 2
  • Perception among family members and physicians about the recommendation for...
    2025, Vol.36, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 14 de abril de 2025.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/